Abstract
Cysteine proteases are important therapeutic targets for numerous disease states including arthritis, osteoporosis, African sleeping sickness and Chagas disease. They have been shown to be viable drug targets for parasitic diseases through in vitro and animal model studies. This review examines the development of vinyl sulfone containing cysteine protease inhibitors. Peptidyl vinyl sulfones are superior inhibitors as they comprise the reactive vinyl sulfone warhead in addition to the peptide backbone, which has complementarity with the enzyme active site. The design, synthesis and activity of these protease inhibitors are discussed. Additionally, different methods for the preparation of vinyl sulfones are presented.
Keywords: Cruzain, cysteine proteases, parasitic inhibiotrs, peptides, rhodesain, vinyl sulfones, therapeutics targets, drug targets, parasitic diseases, metalloproteases
Current Bioactive Compounds
Title: Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors
Volume: 7 Issue: 4
Author(s): Elizabeth Dunny and Paul Evans
Affiliation:
Keywords: Cruzain, cysteine proteases, parasitic inhibiotrs, peptides, rhodesain, vinyl sulfones, therapeutics targets, drug targets, parasitic diseases, metalloproteases
Abstract: Cysteine proteases are important therapeutic targets for numerous disease states including arthritis, osteoporosis, African sleeping sickness and Chagas disease. They have been shown to be viable drug targets for parasitic diseases through in vitro and animal model studies. This review examines the development of vinyl sulfone containing cysteine protease inhibitors. Peptidyl vinyl sulfones are superior inhibitors as they comprise the reactive vinyl sulfone warhead in addition to the peptide backbone, which has complementarity with the enzyme active site. The design, synthesis and activity of these protease inhibitors are discussed. Additionally, different methods for the preparation of vinyl sulfones are presented.
Export Options
About this article
Cite this article as:
Dunny Elizabeth and Evans Paul, Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors, Current Bioactive Compounds 2011; 7 (4) . https://dx.doi.org/10.2174/157340711798375859
DOI https://dx.doi.org/10.2174/157340711798375859 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytoprotective and Antiproliferative Effects of HMG-CoA Reductase Inhibitors
Current Enzyme Inhibition Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Elevated Serum Human Cytomegalovirus IgM Levels in the Acute Phase of Ischemic Stroke are Associated with Increased Risk of Death and Major Disability
Current Neurovascular Research A Brief History of ‘Lone’ Atrial Fibrillation: From ‘A Peculiar Pulse Irregularity’ to a Modern Public Health Concern
Current Pharmaceutical Design Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
Current Molecular Medicine Safety and Efficacy of Novel Oral Anticoagulants: A Comparison to Vitamin K Antagonists
Cardiovascular & Hematological Agents in Medicinal Chemistry Statins in the Prevention of Cardiovascular Events in Patients with Renal Failure
Cardiovascular & Hematological Disorders-Drug Targets Interaction Between Platelets and Cytokines - A Possible Role in the Pathogenesis of Preeclampsia
Vascular Disease Prevention (Discontinued) Restless Legs Syndrome in Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Endothelial Dysfunction, Oxidative Stress and Inflammation in Atherosclerosis: Beneficial Effects of Statins
Current Medicinal Chemistry New Drugs for HDL-C Disorders: The Beginning
Current Medicinal Chemistry Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis
Current Medicinal Chemistry Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry Unusual Food Allergy: AlioideaAllergic Reactions Overview
Recent Patents on Inflammation & Allergy Drug Discovery Prevention of Respiratory Syncytial Virus: A Review
Current Respiratory Medicine Reviews Dietary Fish Oil Reduces Colon Cancer Risk
Current Organic Chemistry α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease
Current Alzheimer Research Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Contactless Core-temperature Monitoring by Infrared Thermal Sensor using Mean Absolute Error Analysis
Recent Patents on Engineering